| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2021-09-24 21:03:08 UTC |
|---|
| Update Date | 2021-09-24 21:03:08 UTC |
|---|
| HMDB ID | HMDB0304890 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | Binimetinib |
|---|
| Description | Binimetinib, also known as MEK162 or mektovi, belongs to the class of organic compounds known as 3-halobenzoic acids and derivatives. These are benzoic acids or derivatives carrying a halogen atom at the 3-position of the benzene ring. Based on a literature review a significant number of articles have been published on Binimetinib. |
|---|
| Structure | CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO InChI=1S/C17H15BrF2N4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26) |
|---|
| Synonyms | | Value | Source |
|---|
| 5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-1,3-benzodiazole-6-carboxamide | ChEBI | | 5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide | ChEBI | | ARRY 162 | ChEBI | | ARRY 438162 | ChEBI | | ARRY-162 | ChEBI | | ARRY-438162 | ChEBI | | Binimetinibum | ChEBI | | MEK-162 | ChEBI | | MEK162 | ChEBI | | Mektovi | ChEBI | | N-(2-Hydroxyethoxy)-4-fluoro-5-(2-fluoro-4-bromophenylamino)-1-methyl-1H-benzoimidazole-6-carboxamide | ChEBI | | NVP-MEK162 | ChEBI | | MEK-162arry-438162binimetinib | ChEMBL | | 5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-1,3-benzodiazole-6-carboximidate | Generator |
|
|---|
| Chemical Formula | C17H15BrF2N4O3 |
|---|
| Average Molecular Weight | 441.233 |
|---|
| Monoisotopic Molecular Weight | 440.02956 |
|---|
| IUPAC Name | 5-[(4-bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-1,3-benzodiazole-6-carboxamide |
|---|
| Traditional Name | 6-[(4-bromo-2-fluorophenyl)amino]-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-1,3-benzodiazole-5-carboxamide |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO |
|---|
| InChI Identifier | InChI=1S/C17H15BrF2N4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26) |
|---|
| InChI Key | ACWZRVQXLIRSDF-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 3-halobenzoic acids and derivatives. These are benzoic acids or derivatives carrying a halogen atom at the 3-position of the benzene ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Benzoic acids and derivatives |
|---|
| Direct Parent | 3-halobenzoic acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - 3-halobenzoic acid or derivatives
- Benzimidazole
- Aniline or substituted anilines
- Bromobenzene
- Fluorobenzene
- Halobenzene
- Aryl bromide
- Aryl fluoride
- Aryl halide
- N-substituted imidazole
- Primary aromatic amine
- Azole
- Heteroaromatic compound
- Imidazole
- Vinylogous amide
- Amino acid or derivatives
- Secondary amine
- Carboxylic acid derivative
- Azacycle
- Organoheterocyclic compound
- Organofluoride
- Organohalogen compound
- Organobromide
- Amine
- Hydrocarbon derivative
- Alcohol
- Organic oxide
- Organic oxygen compound
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Primary alcohol
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 12.7116 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.09 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2717.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 479.8 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 173.0 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 254.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 239.2 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 755.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 886.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 86.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1404.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 552.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1864.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 446.3 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 458.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 358.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 243.9 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 35.3 seconds | 40023050 |
Predicted Kovats Retention IndicesDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Binimetinib,2TMS,isomer #1 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3F)[Si](C)(C)C)=C(C(=O)NOCCO[Si](C)(C)C)C=C21 | 3208.8 | Semi standard non polar | 33892256 | | Binimetinib,2TMS,isomer #1 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3F)[Si](C)(C)C)=C(C(=O)NOCCO[Si](C)(C)C)C=C21 | 3004.4 | Standard non polar | 33892256 | | Binimetinib,2TMS,isomer #1 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3F)[Si](C)(C)C)=C(C(=O)NOCCO[Si](C)(C)C)C=C21 | 3798.8 | Standard polar | 33892256 | | Binimetinib,2TMS,isomer #2 | CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C(=O)N(OCCO[Si](C)(C)C)[Si](C)(C)C)C=C21 | 3348.9 | Semi standard non polar | 33892256 | | Binimetinib,2TMS,isomer #2 | CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C(=O)N(OCCO[Si](C)(C)C)[Si](C)(C)C)C=C21 | 2809.4 | Standard non polar | 33892256 | | Binimetinib,2TMS,isomer #2 | CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C(=O)N(OCCO[Si](C)(C)C)[Si](C)(C)C)C=C21 | 3992.4 | Standard polar | 33892256 | | Binimetinib,2TMS,isomer #3 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3F)[Si](C)(C)C)=C(C(=O)N(OCCO)[Si](C)(C)C)C=C21 | 3215.0 | Semi standard non polar | 33892256 | | Binimetinib,2TMS,isomer #3 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3F)[Si](C)(C)C)=C(C(=O)N(OCCO)[Si](C)(C)C)C=C21 | 2936.3 | Standard non polar | 33892256 | | Binimetinib,2TMS,isomer #3 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3F)[Si](C)(C)C)=C(C(=O)N(OCCO)[Si](C)(C)C)C=C21 | 3834.6 | Standard polar | 33892256 | | Binimetinib,3TMS,isomer #1 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3F)[Si](C)(C)C)=C(C(=O)N(OCCO[Si](C)(C)C)[Si](C)(C)C)C=C21 | 3224.0 | Semi standard non polar | 33892256 | | Binimetinib,3TMS,isomer #1 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3F)[Si](C)(C)C)=C(C(=O)N(OCCO[Si](C)(C)C)[Si](C)(C)C)C=C21 | 2946.0 | Standard non polar | 33892256 | | Binimetinib,3TMS,isomer #1 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3F)[Si](C)(C)C)=C(C(=O)N(OCCO[Si](C)(C)C)[Si](C)(C)C)C=C21 | 3543.5 | Standard polar | 33892256 | | Binimetinib,2TBDMS,isomer #1 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3F)[Si](C)(C)C(C)(C)C)=C(C(=O)NOCCO[Si](C)(C)C(C)(C)C)C=C21 | 3644.3 | Semi standard non polar | 33892256 | | Binimetinib,2TBDMS,isomer #1 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3F)[Si](C)(C)C(C)(C)C)=C(C(=O)NOCCO[Si](C)(C)C(C)(C)C)C=C21 | 3420.3 | Standard non polar | 33892256 | | Binimetinib,2TBDMS,isomer #1 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3F)[Si](C)(C)C(C)(C)C)=C(C(=O)NOCCO[Si](C)(C)C(C)(C)C)C=C21 | 3907.4 | Standard polar | 33892256 | | Binimetinib,2TBDMS,isomer #2 | CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C(=O)N(OCCO[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C21 | 3760.9 | Semi standard non polar | 33892256 | | Binimetinib,2TBDMS,isomer #2 | CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C(=O)N(OCCO[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C21 | 3156.8 | Standard non polar | 33892256 | | Binimetinib,2TBDMS,isomer #2 | CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C(=O)N(OCCO[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C21 | 4069.9 | Standard polar | 33892256 | | Binimetinib,2TBDMS,isomer #3 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3F)[Si](C)(C)C(C)(C)C)=C(C(=O)N(OCCO)[Si](C)(C)C(C)(C)C)C=C21 | 3636.3 | Semi standard non polar | 33892256 | | Binimetinib,2TBDMS,isomer #3 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3F)[Si](C)(C)C(C)(C)C)=C(C(=O)N(OCCO)[Si](C)(C)C(C)(C)C)C=C21 | 3340.5 | Standard non polar | 33892256 | | Binimetinib,2TBDMS,isomer #3 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3F)[Si](C)(C)C(C)(C)C)=C(C(=O)N(OCCO)[Si](C)(C)C(C)(C)C)C=C21 | 3914.1 | Standard polar | 33892256 | | Binimetinib,3TBDMS,isomer #1 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3F)[Si](C)(C)C(C)(C)C)=C(C(=O)N(OCCO[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C21 | 3815.9 | Semi standard non polar | 33892256 | | Binimetinib,3TBDMS,isomer #1 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3F)[Si](C)(C)C(C)(C)C)=C(C(=O)N(OCCO[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C21 | 3461.2 | Standard non polar | 33892256 | | Binimetinib,3TBDMS,isomer #1 | CN1C=NC2=C(F)C(N(C3=CC=C(Br)C=C3F)[Si](C)(C)C(C)(C)C)=C(C(=O)N(OCCO[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C21 | 3754.2 | Standard polar | 33892256 |
|
|---|
| MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Binimetinib 10V, Positive-QTOF | splash10-0006-5004900000-b5fe782069d673930504 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Binimetinib 20V, Positive-QTOF | splash10-03di-2009000000-6a5322fdd46ce27f8e4e | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Binimetinib 40V, Positive-QTOF | splash10-0002-9006000000-7d5a18a713ef987e49f4 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Binimetinib 10V, Negative-QTOF | splash10-000i-1104900000-e122a617640e3b9b77e6 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Binimetinib 20V, Negative-QTOF | splash10-000i-4109300000-1fde364fb97f0ad73b54 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Binimetinib 40V, Negative-QTOF | splash10-029l-3309000000-6e5c49dd9f11f550bd06 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Binimetinib 10V, Negative-QTOF | splash10-004r-0009500000-cb8f3fe297b2156eac06 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Binimetinib 20V, Negative-QTOF | splash10-004i-2009100000-60170205a9d6837dc9b9 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Binimetinib 40V, Negative-QTOF | splash10-004i-5009000000-7f771875c640ba994159 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Binimetinib 10V, Positive-QTOF | splash10-0006-0001900000-22b137df0195f4d6b3c1 | 2021-10-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Binimetinib 20V, Positive-QTOF | splash10-0006-0005900000-86287f3d21a325c0415e | 2021-10-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Binimetinib 40V, Positive-QTOF | splash10-00dr-0159000000-ae88743e32b2cca577fd | 2021-10-22 | Wishart Lab | View Spectrum |
|
|---|